For what it' s worth...
Immunotherapies currently has 4 studies - HSV2 (now waiting for a partner) plus three HPV projects all of which have only just started or about to start.
In other words there aren't going to be any results for a year or so...
WP has also said every dime will be turned over twice before being spent.
Personally, I'll revisit immunotherapies in a year or so.
It's all about Adapt and going CF+ in Q1 FY18 (and nothing else).
For what it' s worth... Immunotherapies currently has 4 studies...
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.60 |
Change
-0.100(0.53%) |
Mkt cap ! $357.5M | |||
| Open | High | Low | Value | Volume |
| $18.70 | $18.77 | $18.21 | $664.1K | 35.88K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $18.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.69 | 53 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |